Skip to main content
Tech.euFundingExplorerBeta

Oncostellae

Development of new pharmaceutical compounds for the treatment of inflamed intestine, colon cancer and immune diseases

Oncostellae has raised €4.3M across 4 funding rounds from 9 investors, most recently a round in Jul 2023. Based in Santiago de Compostela, Spain; active in Healthtech. Data as of 28 Oct 2026.

Santiago de Compostela, Spainoncostellae.com ↗
Total raised
€4.3M
€4,300,000
Funding rounds
4
Investors
9
distinct backers
Active since
2022-07
latest 2023-07

Funding by year

EUR raised per year
Oncostellae — funding by year — interactive chart.
Data table
Oncostellae — funding by year
2022€3.8M
2023€500k

Signals

High confidence
Raise-next likelihood5
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds

Similar companies

same sector or country

Global coverage: FundingData